Get started
Work

Supplementary Table S3 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma

Year: 2024
Type: supplementary-materials
Abstract: Table S3: Comparison of ARO-HIF2 Plasma Exposures Following the First and the Third Weekly Dose
DOI: 10.1158/1078-0432.25956221
Authors: James Brugarolas, Gregory Obara, Kathryn E. Beckermann, Brian Rini, Elaine T. Lam, James Hamilton, Thomas Schluep, Min Yi, So Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M. Tannir
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4399298254
Cites:
Cited by:
Related to: 10